- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/04 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
Patent holdings for IPC class C07D 295/04
Total number of patents in this class: 119
10-year publication summary
|
1
|
5
|
9
|
10
|
7
|
7
|
8
|
3
|
5
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Crinetics Pharmaceuticals, Inc. | 127 |
9 |
| The Regents of the University of California | 20720 |
7 |
| Commissariat à l'énergie atomique et aux energies alternatives | 11127 |
4 |
| Amyris, Inc. | 371 |
4 |
| Bristol-myers Squibb Company | 4729 |
3 |
| Janssen Pharmaceutica N.V. | 3171 |
3 |
| Sanofi | 4293 |
3 |
| Celltaxis, LLC | 29 |
3 |
| Chemo Research, S.L. | 102 |
2 |
| Ligand Pharmaceuticals Incorporated | 167 |
2 |
| Ono Pharmaceutical Co., Ltd. | 422 |
2 |
| Palatin Technologies, Inc. | 61 |
2 |
| Ramot at Tel-Aviv University Ltd. | 1542 |
2 |
| ST Pharm Co., Ltd. | 89 |
2 |
| UDC Ireland Limited | 508 |
2 |
| Vanderbilt University | 2019 |
2 |
| Escalier Biosciences, BV | 6 |
2 |
| Lipidio Pharmaceuticals Inc. | 8 |
2 |
| Wuhan Humanwell Innovative Drug Research and Development Center Limited Company | 133 |
2 |
| Merck Sharp & Dohme LLC | 3735 |
2 |
| Other owners | 59 |